Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

250 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Protective heterologous T cell immunity in COVID-19 induced by MMR and Tdap vaccine antigens.
Mysore V, Cullere X, Settles ML, Ji X, Kattan MW, Desjardins M, Durbin-Johnson B, Gilboa T, Baden LR, Walt DR, Lichtman A, Jehi L, Mayadas TN. Mysore V, et al. Among authors: walt dr. bioRxiv [Preprint]. 2021 May 4:2021.05.03.441323. doi: 10.1101/2021.05.03.441323. bioRxiv. 2021. Update in: Med. 2021 Sep 10;2(9):1050-1071.e7. doi: 10.1016/j.medj.2021.08.004 PMID: 33972940 Free PMC article. Updated. Preprint.
Ultra-Sensitive High-Resolution Profiling of Anti-SARS-CoV-2 Antibodies for Detecting Early Seroconversion in COVID-19 Patients.
Norman M, Gilboa T, Ogata AF, Maley AM, Cohen L, Cai Y, Zhang J, Feldman JE, Hauser BM, Caradonna TM, Chen B, Schmidt AG, Alter G, Charles RC, Ryan ET, Walt DR. Norman M, et al. Among authors: walt dr. medRxiv [Preprint]. 2020 May 2:2020.04.28.20083691. doi: 10.1101/2020.04.28.20083691. medRxiv. 2020. PMID: 32511657 Free PMC article. Preprint.
Evaluation of two commercial and two non-commercial immunoassays for the detection of prior infection to SARS-CoV-2.
Nilles EJ, Karlson EW, Norman M, Gilboa T, Fischinger S, Atyeo C, Zhou G, Bennett CL, Tolan NV, Oganezova K, Walt DR, Alter G, Simmons DP, Schur P, Jarolim P, Baden LR. Nilles EJ, et al. Among authors: walt dr. medRxiv [Preprint]. 2020 Jun 26:2020.06.24.20139006. doi: 10.1101/2020.06.24.20139006. medRxiv. 2020. Update in: J Appl Lab Med. 2021 Nov 1;6(6):1561-1570. doi: 10.1093/jalm/jfab072 PMID: 32607518 Free PMC article. Updated. Preprint.
Ultra-Sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease.
Ogata AF, Maley AM, Wu C, Gilboa T, Norman M, Lazarovits R, Mao CP, Newton G, Chang M, Nguyen K, Kamkaew M, Zhu Q, Gibson TE, Ryan ET, Charles RC, Marasco WA, Walt DR. Ogata AF, et al. Among authors: walt dr. Clin Chem. 2020 Dec 1;66(12):1562-1572. doi: 10.1093/clinchem/hvaa213. Clin Chem. 2020. PMID: 32897389 Free PMC article.
Activity of mRNA COVID-19 vaccines in patients with lymphoid malignancies.
Crombie JL, Sherman AC, Cheng CA, Ryan CE, Zon R, Desjardins M, Baker P, McDonough M, Izaguirre N, Bausk B, Krauss J, Gilboa T, Senussi Y, Walt DR, Davids MS, Brown JR, Armand P, Baden LR, Issa N. Crombie JL, et al. Among authors: walt dr. Blood Adv. 2021 Aug 24;5(16):3062-3065. doi: 10.1182/bloodadvances.2021005328. Blood Adv. 2021. PMID: 34387646 Free PMC article. No abstract available.
A Modular Biomaterial Scaffold-Based Vaccine Elicits Durable Adaptive Immunity to Subunit SARS-CoV-2 Antigens.
Langellotto F, Dellacherie MO, Yeager C, Ijaz H, Yu J, Cheng CA, Dimitrakakis N, Seiler BT, Gebre MS, Gilboa T, Johnson R, Storm N, Bardales S, Graveline A, White D, Tringides CM, Cartwright MJ, Doherty EJ, Honko A, Griffiths A, Barouch DH, Walt DR, Mooney DJ. Langellotto F, et al. Among authors: walt dr. Adv Healthc Mater. 2021 Nov;10(22):e2101370. doi: 10.1002/adhm.202101370. Epub 2021 Oct 4. Adv Healthc Mater. 2021. PMID: 34605223 Free PMC article.
250 results